Search Results - "Pleil, A"

The Reliability Of The Patient-Reported Scar Evaluation Questionnaire (Pr-Seq) In A Cohort Of Adults With Linear Scars by Pleil, A, Mathias, A, Galipeau, N, Shields, A, Jensen, J

Get full text

Is a picture worth a thousand words? the development of a clinician and patient reported photonumeric guide to assess scar severity by Pleil, A, Jensen, J, Galipeau, N, Shields, A

Get full text

PDB55 The Adaptation of the Injection Pen Assessment Questionnaire for Use in Europe – Validation Results From a Large Multicenter Study of Recombinant Human Growth Hormone Treatment NaÏve Children and Adults by Pleil, A, Kimel, M, Wollmann, H

Get full text

Clinical Significance of Change in the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) Score in Adult Growth Hormone Deficiency (AGHD) by Wiid, Z, Pleil, A, Ho, K, Holdaway, I, Cutfield, W, Bullinger, M, Koltowska-Häggström, M, Mardekian, J

Get full text

PSS27 Do Scars Impact Beyond Just Appearance? A Report of the Content Elicitation (CE) Phase in the Development of the Patient Reported Scar Evaluation Quesionnaire (PR-SEQ) by Pleil, A, Jensen, J, Galipeau, N, Olude, O, Klemm, M, Shields, A

Get full text

Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement by Dahl, O. E., Pleil, A. M.

“…Clinical guidelines recommend the use of extended out‐of‐hospital thromboprophylaxis in patients who have had major arthroplasty. However, the…”
Get full text

PSS15 DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISUAL FUNCTIONING QUESTIONNAIRE (NEI-VFQ) by Kymes, S, Peters, C.M, Beusterien, K, Kotak, S, Grinspan, J, Stwalley, D, Pleil, A

Get full text

Comparison of Length of Hospital Stay for Patients with Known or Suspected Methicillin-Resistant Staphylococcus Species Infections Treated with Linezolid or Vancomycin: A Randomized, Multicenter Trial by Li, Zhiming, Willke, Richard J., Pinto, Lionel A., Rittenhouse, Brian E., Rybak, Michael J., Pleil, Andreas M., Crouch, Charles W., Hafkin, Barry, Glick, Henry A.

“…Study Objective. To compare hospital length of stay (LOS), weekly discharges, and days of antibiotic treatment with linezolid (intravenous with oral follow‐up)…”
Get full text

False positive results: a challenge for psychiatric screening in primary care by LEON, A. C, PORTERA, L, OLFSON, M, WEISSMAN, M. M, KATHOL, R. G, FARBER, L, SHEEHAN, D. V, PLEIL, A. M

“…OBJECTIVE: The goal of this study was to characterize primary care patients with false positive results on screens for mental disorders. METHOD: A sample of…”
Get full text

Multinational Study of Reliability and Validity of the King's Health Questionnaire in Patients with Overactive Bladder by Pat Ray Reese, Andreas M. Pleil, Okano, Gary J., Con J. Kelleher

“…Objective: Overactive bladder (OAB) has substantial impact on health-related quality of life (HRQoL). The purpose of this research was to evaluate the…”
Get full text

PDB125 - A DISCRETE CHOICE EXERCISE TO EVALUATE FACTORS DRIVING GROWTH HORMONE DEFICIENT (GHD) PATIENT PREFERENCES FOR INJECTION AND INJECTION DEVICE FEATURES by McNamara, M., Westhead, H., Gross, H., Turner-Bowker, D.M., Yaworsky, A., Pleil, A., Loftus, J.V.

Get full text

PSY34 - Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products: Real-World Analysis in Japan by Karumori, T, Chhabra, A, Alvir, J, Fogarty, PF, Spurden, D, Tortella, BJ, Rubinstein, E, Pleil, A

Get full text

Real World Factor Dispensation and Expenditures in us Patients with Hemophilia B: Standard Half-Life vs. Extended Half-Life Factor IX Replacement Products by Chhabra, A, Spurden, D, Tortella, BJ, Fogarty, PF, Pleil, A, Rubinstein, E, Alvir, J

Get full text

Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products: Real-World Analysis in Japan by Karumori, T, Chhabra, A, Alvir, J, Fogarty, PF, Spurden, D, Tortella, BJ, Rubinstein, E, Pleil, A

Get full text

PSY35 - Real World Factor Dispensation and Expenditures in us Patients with Hemophilia B: Standard Half-Life vs. Extended Half-Life Factor IX Replacement Products by Chhabra, A, Spurden, D, Tortella, BJ, Fogarty, PF, Pleil, A, Rubinstein, E, Alvir, J

Get full text

PSY110 - Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B: Standard half-Life Vs. Extended Half-Life Products by Spurden, D, Chhabra, A, Tortella, BJ, Fogarty, PF, Rubinstein, E, Pleil, A, Alvir, J

Get full text

Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B: Standard half-Life Vs. Extended Half-Life Products by Spurden, D, Chhabra, A, Tortella, BJ, Fogarty, PF, Rubinstein, E, Pleil, A, Alvir, J

Get full text

Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment by McNamara, Michelle, Turner-Bowker, Diane M, Westhead, Hal, Yaworsky, Andrew, Palladino, Andrew, Gross, Hillary, Pleil, Andy, Loftus, Jane

“…The daily injection burden of recombinant human growth hormone (r-hGH) replacement therapy to treat growth hormone deficiency (GHD) may reduce compliance and…”
Get full text

PSY130 - Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products by Spurden, D, Fogarty, PF, Chhabra, A, Tortella, BJ, Alvir, J, Hodge, J, McDonald, M, Pleil, A

Get full text

PSY14 - Real-World Health Care Expenditure In Hemophilia A Patients Using Standard and Extended Half-Life Recombinant Factor Viii Products by Chhabra, A, Tortella, BJ, Alvir, J, Estevez, C, Spurden, D, Hodge, J, McDonald, M, Pleil, A

Get full text